Head and Neck Squamous Cell Carcinoma

Disease State Hub

Pearls of Wisdom

Research Summaries

FDA Alert

FDA Approves Pembrolizumab for Adults with Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

07/21/2025

Kate Young

The FDA announced on June 12 that it has approved pembrolizumab for adult patients with resectable locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors express PD-L1.

07/21/2025

conference coverage

High Opioid Use in Patients With Head, Neck Cancer Undergoing Treatment

04/17/2023

Leigh Precopio

In a recent study presented at the Hematology/Oncology Pharmacy Association annual conference, researchers examined the use of opioids in patients with head and neck squamous cell carcinoma while undergoing...

04/17/2023

June 2026

Current Issue

June 2026